1. A. Before releasing prescription monitoring program data, the Board or its designee shall receive a written or electronic request for controlled substance prescription information.

2. B. A person authorized to access CSPMP data under R4-23-503(C)(1) through (7) shall submit a written or electronic request that:

   1. 1. Specifies the information requested for the report;
   2. 2. For a medical practitioner, provides a statement that the report’s purpose is to provide medical or pharmaceutical care to a patient or to evaluate a patient;
   3. 3. For an individual obtaining the individual’s own controlled substance prescription information, provides a form of non-expired government-issued photo identification;
   4. 4. For a professional licensing board, states that the information is necessary for an open investigation or complaint;
   5. 5. For a local, state, or federal law enforcement or criminal justice agency, states that the information is necessary for an open investigation or complaint;
   6. 6. For the AHCCCS Administration, states that the information is necessary for an open investigation or complaint; and
   7. 7. For a person serving a lawful order of a court of competent jurisdiction, provides a copy of the court order.
3. C. The Board or its designee may provide reports through U.S. mail, other common carrier, facsimile, or secured electronic media or may allow reports to be picked up in-person at the Board office.

Historical Note

Former Rules 5.7100, 5.8100, 5.8500, 5.9100, and 5.9500; Amended effective August 10, 1978 (Supp. 78-4). Repealed effective August 2, 1982 (Supp. 82-4). New Section made by final rulemaking at 14 A.A.R. 3410, effective October 4, 2008 (Supp. 08-3). Section expired under A.R.S. § 41-1056(J) at 20 A.A.R. 133, effective August 30, 2013 (Supp. 14-1). New Section made by final rulemaking at 20 A.A.R. 1359, effective August 2, 2014 (Supp. 14-2).